Navigation Links
Antiretroviral Drugs May Prevent Vaginal Transmission of HIV

Mouse study shows they could protect against spread of disease

TUESDAY, Jan. 15 (HealthDay News) -- Antiretroviral drugs used to treat people with HIV might also prevent vaginal transmission of the virus, claims a study by researchers at the University of Texas Southwestern Medical Center at Dallas.

The vast majority of new HIV infections worldwide, which total about 6,800 new transmissions daily, occur through unprotected vaginal sex with an infected partner.

For this study, the researchers used special mice with fully developed human immune systems that produced the infection-fighting cells specifically targeted by HIV in people. The Texas team found that daily doses of antiretroviral drugs before and after exposure to HIV can prevent vaginal transmission of the virus.

HIV was introduced vaginally into the mice. None of the mice that received the antiretroviral drugs emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) showed any evidence of infection, while 90 percent of mice that didn't receive the drugs became infected by HIV.

The study was published in the Jan. 14 online issue of PLoS Medicine.

"Our motivation is to look for interventions that can be implemented rapidly and have the potential to make a big difference," senior study author Dr. J. Victor Garcia-Martinez, a professor of internal medicine, said in a prepared statement.

"We don't want something in 10 years. We want female-controlled prevention measures now. Our observations support the potential for antiviral drugs to function as an effective pre-exposure prophylaxis against the further spread of AIDS," Garcia-Martinez said.

More information

The New Mexico AIDS Education and Training Center has more about HIV/AIDS drugs.

-- Robert Preidt

SOURCE: University of Texas Southwestern Medical Center at Dallas, news release, Jan. 14, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: